Tag Archives: CAR-T immunotherapy

One month ago we discussed how the CRISPR genome-editing tool offers promise in cancer immunotherapy. The revolutionary gene-editing technology CRISPR-Cas9 is often described as “molecular scissors” for its ability to turn previously improbable feats of genetic engineering into exercises in … Continue reading

Posted in Clinical Trials, Genetic Screening & Testing, Information Strength, Research News, We Live You®: The Latest | Tagged , , , , | Comments Off

Earlier today we posted a column discussing the first use of the gene editing technique CRISPR-Cas9 in a patient with late-stage throat cancer, in hopes of eradicating the disease. This report from the Memorial Sloan-Kettering Cancer Center in New York, … Continue reading

Posted in Genetic Screening & Testing, Information Strength, International Authority, Research News, We Live You®: The Latest | Tagged , , , , | Comments Off

Offering hope for the New Year comes this story. A new cancer treatment called CAR-T cell immunotherapy has for the first time been found to work in a solid tumor cancers, offering hope this technique could be used to target … Continue reading

Posted in Clinical Trials, Information Strength, Research News, We Live You®: The Latest | Tagged , , | Comments Off